Compare SENS & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SENS | INGN |
|---|---|---|
| Founded | 1996 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.2M | 172.4M |
| IPO Year | 2014 | 2013 |
| Metric | SENS | INGN |
|---|---|---|
| Price | $5.94 | $6.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $18.38 | $11.25 |
| AVG Volume (30 Days) | ★ 995.5K | 315.0K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.42 |
| EPS | N/A | ★ N/A |
| Revenue | $16,389,000.00 | ★ $348,668,000.00 |
| Revenue This Year | $74.15 | $8.03 |
| Revenue Next Year | $58.60 | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 19.85 | 3.86 |
| 52 Week Low | $0.41 | $5.34 |
| 52 Week High | $8.75 | $9.13 |
| Indicator | SENS | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 46.62 | 43.16 |
| Support Level | $5.41 | $5.97 |
| Resistance Level | $8.55 | $6.93 |
| Average True Range (ATR) | 0.46 | 0.37 |
| MACD | -0.12 | -0.05 |
| Stochastic Oscillator | 41.92 | 13.08 |
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.